000			01140nam a2200349Ia 4500
001			24171
003			CSIR-IIIM
005			20200219112643.0
008			130912s9999 xx 000 0 und d
020			_a0-8247-8484-7
040			_cCSIR-IIIM _aCSIR-IIIM _benglish
080			_a615.015
100			_4Welling, Peter G.; ed.
245			_aPharmaceutical Bioequivalence _c/Welling, Peter G.; ed.
260			_aNew York
260			_bMarcel Dekker, Inc.
260			_c1991
300			_aix, 467p.
440			_pDrugs and the Pharmaceutical Sciences _vV.48
650			_aBioequivalenc Testing
650			_aBioequivalence
650			_aDrug evalution
650			_aDRUGS-BIOAVAILABILITY
650			_aDrugs-Therapeutic equivalency
650			_aPharmacodynamic Models
650			_aSpecies Differences
653			_aBIOEQUIVALENCE
653			_aPHARMACEUTICAL
700			_4Tse, Francis L.S.; ed. _4Dighe, Shrikant V.; ed.
856			_uhttp://library.iiim.res.in:80/cgi-bin/koha/opac-detail.pl?biblionumber=674 _yhttp://library.iiim.res.in:80/cgi-bin/koha/opac-detail.pl?biblionumber=674
942			_cBK _2udc _k615.015 _mN1
999			_c674 _d674